Diseases of Pulmonary Vasculature

Featured Article

Perioperative Risk Assessment in a Patient With COPD

Perioperative Risk Assessment in a Patient With COPD

A 64-year-old man with chronic obstructive pulmonary disease, diabetes, chronic kidney disease, and morbid obesity seeks preoperative approval for femoral popliteal bypass surgery.

Latest Features

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

Lung Transplantation in Pulmonary Arterial Hypertension: An Overview

Evaluating diagnosis and treatment options for pulmonary arterial hypertension.

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

A 40-year-old woman presents with worsening shortness of breath after being treated with long-acting nifedipine for 2 years.

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

Diagnostic Value of Bronchoalveolar Lavage in Idiopathic Pulmonary Fibrosis

The diagnostic value of bronchoalveolar lavage in idiopathic pulmonary fibrosis is evaluated.

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Pulmonary Arterial Hypertension: Treatment Tailored by Race and Ethnicity

Future clinical trials on pulmonary arterial hypertension should include patients from diverse racial and ethnic backgrounds.

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

Bronchopulmonary Dysplasia and Pulmonary Hypertension in Preterm Neonates

The most common chronic respiratory morbidity affecting preterm neonates is bronchopulmonary dysplasia.

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

Pulmonary Complications After Noncardiac Surgery Ameliorated By Pulmonary Rehab

The risk of perioperative complications is increased by many factors in patients undergoing thoracic surgery.

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

James E. Loyd, MD, and Wendy Chung, MD, PhD, offer insight into the role of genetics in pulmonary arterial hypertension.

Latest News

Benefits of Targeted Pharmacologic Therapy in PAH and Distal CTEPH

Benefits of Targeted Pharmacologic Therapy in PAH and Distal CTEPH

In patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension, targeted pharmacologic treatment was associated with an increase in achieved therapeutic goals.

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Pulmonary Arterial Hypertension Outcomes With Atrial Arrhythmia

Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.

Oral Treprostinil Dosing Characteristics in Pulmonary Arterial Hypertension

Oral Treprostinil Dosing Characteristics in Pulmonary Arterial Hypertension

Prescribers tend to favor a frequency of 3 times per day for oral treprostinil dosing in patients with pulmonary arterial hypertension.

Pulmonary Hypertension Outcomes Predicted by NT-pro BNP

Pulmonary Hypertension Outcomes Predicted by NT-pro BNP

N-terminal-pro brain natriuretic peptide may be a useful biomarker for both mortality and respiratory exacerbations in pediatric patients with pulmonary hypertension.

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Pulmonary Hypertension Mortality Following Cardiac Catheterization

Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.

PDE-5 Inhibitor Prescribing Trends Do Not Meet Pulmonary Hypertension Guidelines

PDE-5 Inhibitor Prescribing Trends Do Not Meet Pulmonary Hypertension Guidelines

Nearly two-thirds of phosphodiesterase-5 inhibitor prescriptions are inconsistent with pulmonary hypertension guidelines.

Pulmonary Arterial Hypertension Identified Via Claims-Based Algorithm

Pulmonary Arterial Hypertension Identified Via Claims-Based Algorithm

Patients with pulmonary arterial hypertension may be better identified with the use of a claims-based algorithm that includes ICD-9-CM codes, electronic medical records, and more.

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.

Pulmonary Embolism Risk Prediction in Postpartum Women

Pulmonary Embolism Risk Prediction in Postpartum Women

Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.

Pulmonary Hypertension Treatments Targeting NO Pathway Compared for Safety

Pulmonary Hypertension Treatments Targeting NO Pathway Compared for Safety

Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

To minimize the "learning effect" and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.

Pulmonary Arterial Hypertension: Biomarker May Predict 5-Year Survival

Pulmonary Arterial Hypertension: Biomarker May Predict 5-Year Survival

Monitoring the plasma BNP level in individuals with pulmonary arterial hypertension may aid clinicians in therapeutic decision-making and overall prediction of 5-year survival rate.

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Global Pulmonary Vascular Remodeling and Pulmonary Hypertension in Heart Failure

Researchers discovered an association between global pulmonary vascular remodeling and pulmonary hypertension in patients with heart failure.

Assessment of Ambrisentan in Pulmonary Arterial Hypertension

Assessment of Ambrisentan in Pulmonary Arterial Hypertension

In a postmarketing surveillance study, ambrisentan demonstrated tolerability and potential effectiveness for pulmonary arterial hypertension treatment.

Sign Up for Free e-Newsletters